Radiopharmaceutical firm Draxis Health will realign its executive management team, beginning in July. The Mississauga, Ontario-based firm said the planned moves reflect the growing importance of its core radiopharmaceuticals and pharmaceutical contract manufacturing businesses in Montreal.
Beginning July 1, the position of chief financial officer (CFO) will be assumed by Mark Oleksiw, currently the firm’s director of finance, who will be based in Montreal. Jim Garner, the current CFO, will leave Draxis to take a position with a Canadian healthcare company in the Toronto region. Garner's responsibilities as acting president of Draxis Pharma, the company’s pharmaceutical contract manufacturing subsidiary, have been assumed by John Durham, who was recently appointed president of the subsidiary.
Also in July, Dan Brazier will assume the position of senior vice president, corporate development and strategic planning. Brazier’s new responsibilities will be in addition to his ongoing role (since 1998) as president of Draxis Pharmaceutica, the firm’s Canadian pharmaceutical sales and marketing division. Draxis is currently in late-stage negotiations for the divestiture of the balance of the assets of this division.
Chien Huang will be promoted to vice president finance effective July 1, 2003, with responsibility for corporate financial management and control, and will serve as financial assistant to the CEO. Huang will be located in the Toronto area, and will provide financial support for a wide range of activities, including strategic planning, corporate development, and investor relations, according to Draxis.
By AuntMinnie.com staff writersJune 3, 2003
Related Reading
DraxImage begins U.S. shipments of I-131 kit, April 3, 2003
Draxis Health reports record earnings, February 6, 2003
DraxImage gets clearance for radiotherapeutic kit, January 29, 2003
Cytogen, Draxis dispute heats up, January 28, 2003
Production of palladium BrachySeed version halted, January 17, 2003
Copyright © 2003 AuntMinnie.com
